FI750371A - - Google Patents

Info

Publication number
FI750371A
FI750371A FI750371A FI750371A FI750371A FI 750371 A FI750371 A FI 750371A FI 750371 A FI750371 A FI 750371A FI 750371 A FI750371 A FI 750371A FI 750371 A FI750371 A FI 750371A
Authority
FI
Finland
Application number
FI750371A
Other languages
Finnish (fi)
Inventor
Masaki Hayashi
Seiji Kori
Hajimu Miyake
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of FI750371A publication Critical patent/FI750371A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
FI750371A 1974-02-13 1975-02-11 FI750371A (US07754267-20100713-C00017.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6610/74A GB1488006A (en) 1974-02-13 1974-02-13 Prostaglandin analogues

Publications (1)

Publication Number Publication Date
FI750371A true FI750371A (US07754267-20100713-C00017.png) 1975-08-14

Family

ID=9817609

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750371A FI750371A (US07754267-20100713-C00017.png) 1974-02-13 1975-02-11

Country Status (13)

Country Link
US (1) US4140712A (US07754267-20100713-C00017.png)
JP (1) JPS50111050A (US07754267-20100713-C00017.png)
AU (1) AU7810075A (US07754267-20100713-C00017.png)
BE (1) BE825459A (US07754267-20100713-C00017.png)
DE (1) DE2505519A1 (US07754267-20100713-C00017.png)
DK (1) DK50775A (US07754267-20100713-C00017.png)
FI (1) FI750371A (US07754267-20100713-C00017.png)
FR (1) FR2260335B1 (US07754267-20100713-C00017.png)
GB (1) GB1488006A (US07754267-20100713-C00017.png)
LU (1) LU71831A1 (US07754267-20100713-C00017.png)
NL (1) NL7501613A (US07754267-20100713-C00017.png)
SE (1) SE7501512L (US07754267-20100713-C00017.png)
ZA (1) ZA75856B (US07754267-20100713-C00017.png)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2265361B1 (US07754267-20100713-C00017.png) * 1974-03-26 1978-07-28 Gist Brocades Nv
USRE30287E (en) * 1974-03-26 1980-05-27 Gist-Brocades N.V. 19 Hydroxy prostaglandins
DK142235B (da) * 1974-12-20 1980-09-29 Yamanouchi Pharma Co Ltd Analogifremgangsmåde til fremstilling af 20-alkoxy-16-methyl-prostadiensyre-derivater.
US4281191A (en) * 1979-04-02 1981-07-28 The Upjohn Company 19-Hydroxy-19-methyl-PG amides
US4259513A (en) * 1979-04-02 1981-03-31 The Upjohn Company 19-Hydroxy-13,14-dihydro-PG1 compounds
US4289904A (en) * 1979-07-05 1981-09-15 The Upjohn Company 19-Hydroxy-6a-carba-PGI2 sulfonylamides
US4267371A (en) * 1979-07-05 1981-05-12 The Upjohn Company 19-Hydroxy-6a-carba-PGI2 amides
US4267352A (en) * 1979-07-05 1981-05-12 The Upjohn Company 19-Hydroxy-19-methyl-6-oxo-PGF1 sulfonylamides
US4312997A (en) * 1979-07-05 1982-01-26 The Upjohn Company 19-Hydroxy-6-oxo-PGF1 amides
US4281150A (en) * 1979-07-05 1981-07-28 The Upjohn Company 19-Hydroxy-19-methyl-6a-carba-PGI2 sulfonylamides
JPS58121243A (ja) * 1982-01-12 1983-07-19 Sumitomo Chem Co Ltd 新規ビシクロオクタン誘導体及びその製造法
DE4014665C2 (de) * 1990-05-08 1994-06-01 Sanol Arznei Schwarz Gmbh Oberflächenvergütete Gläser in Primärpackmitteln von Lyophilisaten und deren Verwendung bei der Herstellung von Lyophilisaten
SE9900025D0 (sv) * 1999-01-08 1999-01-08 Synphora Ab Method and composition for treatment of female sexual dysfunction

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843713A (en) * 1972-04-05 1974-10-22 Ciba Geigy Corp 16-lower alkoxy lower alkyl,-16-20 w-pentano,pge
JPS5432773B2 (US07754267-20100713-C00017.png) * 1972-05-09 1979-10-16
JPS50116453A (US07754267-20100713-C00017.png) * 1974-02-28 1975-09-11

Also Published As

Publication number Publication date
US4140712A (en) 1979-02-20
FR2260335B1 (US07754267-20100713-C00017.png) 1978-07-21
BE825459A (fr) 1975-08-12
JPS50111050A (US07754267-20100713-C00017.png) 1975-09-01
GB1488006A (en) 1977-10-05
DE2505519A1 (de) 1975-08-14
AU7810075A (en) 1976-08-12
NL7501613A (nl) 1975-08-15
FR2260335A1 (US07754267-20100713-C00017.png) 1975-09-05
ZA75856B (en) 1976-01-28
SE7501512L (US07754267-20100713-C00017.png) 1975-08-14
LU71831A1 (US07754267-20100713-C00017.png) 1975-12-09
DK50775A (US07754267-20100713-C00017.png) 1975-10-06

Similar Documents

Publication Publication Date Title
DK125975A (US07754267-20100713-C00017.png)
FI751723A (US07754267-20100713-C00017.png)
FR2260335B1 (US07754267-20100713-C00017.png)
FR2296306B1 (US07754267-20100713-C00017.png)
FR2278637B1 (US07754267-20100713-C00017.png)
FR2275099B1 (US07754267-20100713-C00017.png)
FR2270621B1 (US07754267-20100713-C00017.png)
FR2266360A1 (US07754267-20100713-C00017.png)
DK142235C (US07754267-20100713-C00017.png)
FR2264483A1 (US07754267-20100713-C00017.png)
FR2257833B1 (US07754267-20100713-C00017.png)
FR2281446B3 (US07754267-20100713-C00017.png)
JPS50101544A (US07754267-20100713-C00017.png)
JPS50101292U (US07754267-20100713-C00017.png)
IN142155B (US07754267-20100713-C00017.png)
BG19828A1 (US07754267-20100713-C00017.png)
CH1357474A4 (US07754267-20100713-C00017.png)
BG21272A1 (US07754267-20100713-C00017.png)
BG21285A1 (US07754267-20100713-C00017.png)
BG19772A1 (US07754267-20100713-C00017.png)
DD115531A1 (US07754267-20100713-C00017.png)
DD108885A1 (US07754267-20100713-C00017.png)
BG20983A1 (US07754267-20100713-C00017.png)
BG20886A1 (US07754267-20100713-C00017.png)
BG20864A1 (US07754267-20100713-C00017.png)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: ONO PHARMACEUTICAL CO., LTD.